Intravitreal injections: taking the plunge

29 October 2021
Autumn 2021
AMD Retina

Increasing demand for intravitreal injections to treat conditions such as wet AMD provides an opportunity for optometrists to widen their portfolio of skills, writes Kim Thomas.

Part of the success of the COVID-19 vaccination programme was down to the many optometrists and other healthcare professionals who helped deliver the vaccine. Now the programme is nearing its end, could optometrists use their newly acquired skills to take on another role – that of intravitreal injector?

Sign in to continue

Forgotten password?
Register

Not already a member of the College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

benefits of membership

Related further reading

Supplements and eye health

Reviewing the evidence for the role of supplements in eye health, particularly cataract and age-related macular degeneration (AMD).

AMD Public health

Associations of retinal vessel calibre with cardiovascular disease: a systematic literature rev...

This literature review aims to demonstrate that optometrists are well placed to use this technology in routine practice, in conjunction with measuring systemic BP.

Retina

Optometric management of age-related macular degeneration: Referral and referral refinement pil...

Pilot data from surveys examining the roles of community-based and hospital optometrists in the assessment and management of patients with suspected AMD.

AMD Referrals